Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Even in Japan, Significant Growth Potential for Seven Eleven and Other CVS

Seven & I Holdings (3382 JP): Board’s Plan to Unlock Value Is a Stop-Gap Measure

7&I (3382) - A Starting Point for the Standalone Plan - The Good, The Bad, The Ugly

7&I (3382) Possibility of YUUUUUGE Buyback?

Douglas Research Advisory

Event-Driven

<ul>
<li>If indeed the company proceeds with 2 trillion yen buyback over five years, this would represent buyback of about 7.3% of its shares per year (37% of market cap). </li>
<li>Seven &amp; I Holdings' plans to massively buyback shares and IPO its North American CVS business are major catalysts that should have positive impact both near and long term. </li>
<li>Certainly, the company's action plan to sell its non-core assets (including supermarket, restaurant, and specialty stores) to Bain Capital for $5.5 billion is a step in the right direction.</li>
</ul>


If indeed the company proceeds with 2 trillion yen buyback over five years, this would represent buyback of about 7.3% of its shares per year (37% of market cap). 
Seven &amp; I Holdings' plans to massively buyback shares and IPO its North American CVS business are major catalysts that should have positive impact both near and long term. 
Certainly, the company's action plan to sell its non-core assets (including supermarket, restaurant, and specialty stores) to Bain Capital for $5.5 billion is a step in the right direction.


Seven & I Holdings: Mega Share Buyback Plan and IPO of North American CVS Unit to Boost Share Price